Astec LifeSciences Limited announced its financial results for Q3 FY25, reporting a total income of 95.8 Crore, up 85.2% from 51.7 Crore in Q3 FY24, yet showing a consolidated EBITDA loss of 3.8 Crore, which is an improvement from a loss of 17.4 Cror
AI Assistant
Astec Lifesciences Ltd
2025
Announcement
Find Answers
Ask about any part of the document to get insights, explanations, or key details.